IL-35 mRNA therapy(University of South China)

N/A

Report date: 2026/04/03 20:03:44

Base Information

Drug NameIL-35 mRNA therapy(University of South China)
Drug Alias NameIL-35 mRNAIL-35 mRNA/LNP
ClassificationCell and gene therapy > Gene therapy > LNP
Mechanisms of ActionInterleukin-35 stimulants
TargetsInterleukin-35
Therapy Area/IndicationsPneumonia, Viral
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesUniversity of South China
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of South China
Inactive CompaniesN/A
Active IndicationsPneumonia, Viral
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A